Form 4 holding
CEO and President, Director
RECURSION PHARMACEUTICALS, INC.
- Security class
- Class A Common Stock
- Shares / value
- 2,095,298
- Estimated value
- $7,689,743
- Report date
- 17 Aug 2026
- Price
- $3.67
- Ownership
- Direct